Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information of medroxyprogesterone acetate (MPA)-containing products be amended by updating the safety warnings to include the potential risk of meningioma. MPA is a synthetic oral and injectable form...
The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation's telephone system has been restored. SAHPRA apologises for any inconvenience this may have caused. ...
The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation is currently experiencing a technical issue with its telephone system, which is affecting both outgoing and incoming calls. The Authority's service provider is working diligently to resolve the issue as...
Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavilable today, 29 November 2024 due to the organisation's Annual General Meeting. If you require assistance, please use applicable contacts from Key Contacts: https://www.sahpra.org.za/key-contacts/ ...
SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 December 2024 and will re-open on Monday, 06 January 2025. Please note: Dates, placed within brackets for various email addresses, will guide stakeholders to the timeframes that emails will be processed. Dates, placed within...
Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is aware of a quality issue in a batch of YAZ Plus contraceptives (Batch No. WEW96J distributed on 09 and 24 November 2023) which has resulted in the incorrect arrangement of tablets...
Pretoria, 08 November 2024 –The South African Health Products Regulatory Authority (SAHPRA) is concerned about the proliferation of falsified, compounded and substandard Glucagon-like Peptide (GLP-1)-containing products being made available to the public via websites, social media platforms and other informal channels. These pose a health...
As part of its pharmacovigilance programme, the South African Health Products Regulatory Authority (SAHPRA) recently partnered with the Independent Community Pharmacy Association (ICPA) to deliver an informative webinar on reporting adverse drug events and promoting the safe use of medicines to reduce the occurrence of...
Pretoria, 07 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) encourages members of the public to always report any suspected side effects they may experience from taking medicines, vaccines and/or using medical devices, to help make medicines safer for everyone. While humanity...
The South African Health Product Regulatory Authority (SAHPRA) Complementary Medicines’ (CMs’) Hybrid Workshop successfully took place, offering attendees the option to participate either in person or via a virtual platform. Key areas discussed during the workshop included: SAHPRA responded to the 21 questions regarding Complementary Medicines...
